Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Highly effective treatment with tacrolimus ointment in an adolescent with oral graft-versus-host disease.

Bauters T, Bordon V, Van de Velde V, Van Lancker S, Robays H, Benoit Y, Laureys G.

Pharm World Sci. 2010 Jun;32(3):350-2. doi: 10.1007/s11096-010-9386-9. Epub 2010 Apr 4.

PMID:
20364437
2.
3.

Oral graft vs. host disease in children--treatment with topical tacrolimus ointment.

Albert MH, Becker B, Schuster FR, Klein B, Binder V, Adam K, Nienhoff C, Führer M, Borkhardt A.

Pediatr Transplant. 2007 May;11(3):306-11.

PMID:
17430488
4.

Topical tacrolimus--a novel treatment alternative for cutaneous chronic graft-versus-host disease.

Elad S, Or R, Resnick I, Shapira MY.

Transpl Int. 2003 Sep;16(9):665-70. Epub 2003 May 27.

5.

Long-term result of maintenance treatment with tacrolimus ointment in chronic ocular graft-versus-host disease.

Jung JW, Lee YJ, Yoon SC, Kim TI, Kim EK, Seo KY.

Am J Ophthalmol. 2015 Mar;159(3):519-27.e1. doi: 10.1016/j.ajo.2014.11.035. Epub 2014 Dec 9.

PMID:
25498356
6.
7.

Topical 0.03% tacrolimus ointment in the management of ocular surface inflammation in chronic GVHD.

Tam PM, Young AL, Cheng LL, Lam PT.

Bone Marrow Transplant. 2010 May;45(5):957-8. doi: 10.1038/bmt.2009.249. Epub 2009 Oct 5. No abstract available.

PMID:
19802037
8.

[Gran versus host disease with oral involvement: report of one case].

Rojas A G, González G N, Venables G C, Araos H D.

Rev Med Chil. 2008 Dec;136(12):1570-3. doi: /S0034-98872008001200010. Epub 2009 Mar 23. Spanish.

9.

[Tacrolimus ointment in the treatment of chronic cutaneous graft-versus-host disease].

Firmin D, Karam A, Guillerm G, Roguedas AM, Berthou C, Misery L.

Ann Dermatol Venereol. 2008 Mar;135(3):234-6. doi: 10.1016/j.annder.2007.09.001. Epub 2008 Feb 1. French. No abstract available.

PMID:
18374862
10.
11.

Dramatic increase of tacrolimus plasma concentration during topical treatment for oral graft-versus-host disease.

Conrotto D, Carrozzo M, Ubertalli AV, Gandolfo S, Giaccone L, Boccadoro M, Bruno B.

Transplantation. 2006 Oct 27;82(8):1113-5. No abstract available. Erratum in: Transplantation. 2007 Jan 15;83(1):76. Benedetto, Bruno [corrected to Bruno, Benedetto].

PMID:
17060865
12.

Therapeutic effect of 0.03% tacrolimus ointment for ocular graft versus host disease and vernal keratoconjunctivitis.

Ryu EH, Kim JM, Laddha PM, Chung ES, Chung TY.

Korean J Ophthalmol. 2012 Aug;26(4):241-7. doi: 10.3341/kjo.2012.26.4.241. Epub 2012 Jul 24.

13.

Successful treatment using tacrolimus ointment for cutaneous graft-versus-host disease.

Kunitomi A, Iida H, Kamiya Y, Hayashi M, Sao H.

Int J Hematol. 2008 Nov;88(4):465-7. doi: 10.1007/s12185-008-0197-x. Epub 2008 Nov 11. No abstract available.

PMID:
19002390
14.

Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors.

Nash RA, Antin JH, Karanes C, Fay JW, Avalos BR, Yeager AM, Przepiorka D, Davies S, Petersen FB, Bartels P, Buell D, Fitzsimmons W, Anasetti C, Storb R, Ratanatharathorn V.

Blood. 2000 Sep 15;96(6):2062-8.

15.

FK506 (tacrolimus) in the treatment of steroid-resistant acute graft-versus-host disease in children undergoing bone marrow transplantation.

Koehler MT, Howrie D, Mirro J, Neudorf S, Blatt J, Corey S, Wollman M, Kelly-Ekeroth V, Reyes J.

Bone Marrow Transplant. 1995 Jun;15(6):895-9.

PMID:
7581088
16.
17.

Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation.

Ratanatharathorn V, Nash RA, Przepiorka D, Devine SM, Klein JL, Weisdorf D, Fay JW, Nademanee A, Antin JH, Christiansen NP, van der Jagt R, Herzig RH, Litzow MR, Wolff SN, Longo WL, Petersen FB, Karanes C, Avalos B, Storb R, Buell DN, Maher RM, Fitzsimmons WE, Wingard JR.

Blood. 1998 Oct 1;92(7):2303-14.

18.

Mucosal cell-mediated immunological changes associated with experimental graft-versus-host disease.

Thomas DW, Matthews JB, Prime SS.

J Oral Pathol Med. 1996 Apr;25(4):145-50.

PMID:
8809681
19.
20.

Topical azathioprine in the combined treatment of chronic oral graft-versus-host disease.

Epstein JB, Nantel S, Sheoltch SM.

Bone Marrow Transplant. 2000 Mar;25(6):683-7.

Supplemental Content

Support Center